These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1028797)

  • 1. FDA problems with medications in the marketplace: III. 'Therapeutic orphans'.
    Archambault GF
    Hosp Formul; 1976 Dec; 11(12):690. PubMed ID: 1028797
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapeutic orphans: who speaks for children?
    Shirkey HC
    South Med J; 1970 Nov; 63(11):1361-3. PubMed ID: 5475304
    [No Abstract]   [Full Text] [Related]  

  • 3. FDA problems with medications in the marketplace: II.
    Archambault GF
    Hosp Formul; 1976 May; 11(5):272. PubMed ID: 1026690
    [No Abstract]   [Full Text] [Related]  

  • 4. New pediatric dosage rules: information and testing.
    Feeg VD
    Pediatr Nurs; 1998; 24(6):518, 613. PubMed ID: 10085992
    [No Abstract]   [Full Text] [Related]  

  • 5. FDA labeling status of pediatric medications.
    Yoon EY; Davis MM; El-Essawi H; Cabana MD
    Clin Pediatr (Phila); 2006; 45(1):75-7. PubMed ID: 16429220
    [No Abstract]   [Full Text] [Related]  

  • 6. Characteristics of container labeling in a sample of commonly prescribed children's oral medications.
    Wallace LS; Keenum AJ; DeVoe JE
    Res Social Adm Pharm; 2010 Dec; 6(4):272-9. PubMed ID: 21111385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety-related drug labeling changes approved by FDA.
    White GG
    J Toxicol Clin Toxicol; 1998; 36(3):265-7. PubMed ID: 9678979
    [No Abstract]   [Full Text] [Related]  

  • 8. Paediatric clinical trials: redressing the imbalance.
    Schreiner MS
    Nat Rev Drug Discov; 2003 Dec; 2(12):949-61. PubMed ID: 14654794
    [No Abstract]   [Full Text] [Related]  

  • 9. American Academy of Pediatrics. Committee on drugs. Drug testing in children: FDA regulations.
    Pediatrics; 1969 Mar; 43(3):463-5. PubMed ID: 5818481
    [No Abstract]   [Full Text] [Related]  

  • 10. Medication use in the neonatal intensive care unit: current patterns and off-label use of parenteral medications.
    Kumar P; Walker JK; Hurt KM; Bennett KM; Grosshans N; Fotis MA
    J Pediatr; 2008 Mar; 152(3):412-5. PubMed ID: 18280851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of Food and Drug Administration--approved medications for unlabeled (off-label) uses. The legal and ethical implications.
    Torres A
    Arch Dermatol; 1994 Jan; 130(1):32-6. PubMed ID: 8285737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic orphans.
    Shirkey H
    Pediatrics; 1999 Sep; 104(3 Pt 2):583-4. PubMed ID: 10469793
    [No Abstract]   [Full Text] [Related]  

  • 13. Policy and procedure manual. Use of medications for indications, dosages and/or routes of administration not listed in the FDA literature.
    Curr Concepts Hosp Pharm Manage; 1988; 10(1):20. PubMed ID: 10317998
    [No Abstract]   [Full Text] [Related]  

  • 14. Power of the package insert.
    Chayet NL
    N Engl J Med; 1967 Dec; 277(23):1253-4. PubMed ID: 6072669
    [No Abstract]   [Full Text] [Related]  

  • 15. FDA cracks down on labeling, initiates trial result reporting.
    Osborne R; Waltz E
    Nat Biotechnol; 2008 Nov; 26(11):1203-4. PubMed ID: 18997742
    [No Abstract]   [Full Text] [Related]  

  • 16. FDA problems with medications in the marketplace: I.
    Archambault GF
    Hosp Formul; 1976 Apr; 11(4):224. PubMed ID: 1037449
    [No Abstract]   [Full Text] [Related]  

  • 17. Medicines for children licensed by the European Agency for the Evaluation of Medicinal Products.
    Ceci A; Felisi M; Catapano M; Baiardi P; Cipollina L; Ravera S; Bagnulo S; Reggio S; Rondini G
    Eur J Clin Pharmacol; 2002 Nov; 58(8):495-500. PubMed ID: 12451425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug reactions: the role of the package insert.
    Barnett FJ
    J Leg Med (N Y); 1973; 1(1):19-23. PubMed ID: 4548069
    [No Abstract]   [Full Text] [Related]  

  • 19. Prescription drug abuse: FDA and SAMHSA join forces.
    Meadows M
    FDA Consum; 2003; 37(2):36. PubMed ID: 12715769
    [No Abstract]   [Full Text] [Related]  

  • 20. FDA drug prescribing warnings: is the black box half empty or half full?
    Wagner AK; Chan KA; Dashevsky I; Raebel MA; Andrade SE; Lafata JE; Davis RL; Gurwitz JH; Soumerai SB; Platt R
    Pharmacoepidemiol Drug Saf; 2006 Jun; 15(6):369-86. PubMed ID: 16294363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.